Srilaxmi Kalavalapalli

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril et al. · Diabetes Care · 2020 · 321 citations · Full text

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Fernando Bril, Diane Biernacki, Srilaxmi Kalavalapalli et al. · Diabetes Care · 2019 · 302 citations

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes

Fernando Bril, Srilaxmi Kalavalapalli, Virginia Clark et al. · Clinical Gastroenterology and Hepatology · 2017 · 194 citations

Metabolic Syndrome, Diabetes Management, Hepatology +10

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

Kenneth Cusi, Fernando Bril, Diana Barb et al. · Diabetes Obesity and Metabolism · 2018 · 191 citations

Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity

R. E. Patterson, Srilaxmi Kalavalapalli, Caroline M. Williams et al. · American Journal of Physiology-Endocrinology and Metabolism · 2016 · 155 citations · Full text

Tca Cycle Fluxes, Fatty Liver Disease, Oxidative Stress +20